Evidence map›Paper›PMID 33532461›Full record

ArticleERJ open research2021

Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions.

Victor Margelidon-Cozzolino, Vincent Cottin, Sophie Dupuis-Girod, Julie Traclet, Kais Ahmad, Jean-François Mornex, Ségolène Turquier

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Victor Margelidon-CozzolinoDept of Respiratory Physiology, Hospices Civils de Lyon, Louis Pradel Hospital, Lyon, France.
Vincent CottinCompetence Centre for Severe Pulmonary Hypertension, Reference Centre for Rare Pulmonary Diseases, Dept of Respiratory Medicine, Hospices Civils de Lyon, Louis Pradel Hospital, UMR754, Claude Bernard University Lyon 1, Lyon, France.ORCID https://orcid.org/0000-0002-5591-0955
Sophie Dupuis-GirodNational Reference Centre for Hereditary Hemorrhagic Telangiectasia, Dept of Genetic Medicine, Hospices Civils de Lyon, Louis Pradel Hospital, Lyon, France and Univ. Grenoble Alpes, Inserm, CEA, BIG-Biologie du Cancer et de l'Infection, Grenoble, France.
Julie TracletCompetence Centre for Severe Pulmonary Hypertension, Reference Centre for Rare Pulmonary Diseases, Dept of Respiratory Medicine, Hospices Civils de Lyon, Louis Pradel Hospital, UMR754, Claude Bernard University Lyon 1, Lyon, France.
Kais AhmadCompetence Centre for Severe Pulmonary Hypertension, Reference Centre for Rare Pulmonary Diseases, Dept of Respiratory Medicine, Hospices Civils de Lyon, Louis Pradel Hospital, UMR754, Claude Bernard University Lyon 1, Lyon, France.
Jean-François MornexCompetence Centre for Severe Pulmonary Hypertension, Reference Centre for Rare Pulmonary Diseases, Dept of Respiratory Medicine, Hospices Civils de Lyon, Louis Pradel Hospital, UMR754, Claude Bernard University Lyon 1, Lyon, France.
Ségolène TurquierDept of Respiratory Physiology, Hospices Civils de Lyon, Louis Pradel Hospital, Lyon, France.
Université Claude Bernard Lyon 1 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33532461
PMCPMC7836486
OpenAlexW3110079557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.